**5. References**


[11] Helm RE, Gold JP, Rosengard TK, et al. Erythropoietin in cardiac surgery. J Card Surg

[12] Schmoeckel M, Nollert G, Mempel M, Mempel W, Reichard: Effects of recombinant

[13] Yazicioglu L, Eryilmaz S, Sirlak M, Bahadir M, et al. Recombinant human erythropoietin administration in cardiac surgery. Thorac Cardiovasc Surg 2001;122:741-45. [14] Sowade O, Warnke H, Scigalla P, et al. Avoidance of allogenic blood transfusions by

[15] Weltert L, D'Alessandro S, Nardella S, Girola F, et al. Preoperative very short-term,

[16] Robblee JA, Starr NJ: Blood harvested before cardiopulmonary bypass decreases postoperative blood loss. J Cardiothorac Vasc Anesth 1990;4:519-25. [17] Fang WC, Helm RE, Krieger KH, et al: The impact of low hematocrit during

[18] Toraman F, Karabulut H, Alham C. Is it the patient or the physician who cannot tolerate

[19] Jones JW, McCoy TA, Rawitscher RE, et al: Effects of intraoperative plasmapheresis on

[20] Stammers AH, Kratz J, Johnson T, et al: Hematological assessment of patients

[21] Li S, Ji H, Lin J, et al. Combination of acute preoperative plateletpheresis, cell salvage,

[22] Boldt J, von Borman B, Kling D, et al: Preoparative plasmapheresis in patients

[23] Stammers AH, Rasmussen CR, Kratz JM: The effects of platelet-rich plasma on postcardiopulmonary bypass fibrinolysis. J Extracorpor Technol 1993;25:122. [24] Tobe CE, Vocelka C, Sepulvada R, et al: Infusion of autologous platelet-rich-plasma

[25] Wong CA, Franklin ML, Wade LD: Coagulation tests, blood loss, and transfusion

[26] Boodhwani M, Nathan HJ, Mesana TG, Rubens FD. Effects of shed mediastinal blood on

blood loss in cardiac surgery. Ann Thorac Surg 1990;49:585.

undergoing cardiac surgery. Anesthesiology 1990;72:282-88.

human erythropoietin on autologous blood donation before open heart surgery. J

treatment with epoetin beta [recombinant human erythropoietin] in patients

high-dose erythropoietin administration diminishes blood transfusion rate in offpump coronary artery bypass: A randomized blind controlled study. J Thorac

cardiopulmonary bypass on outcome in patients undergoing coronary artery

anemia? A prospective analysis in 1854 nontransfused coronary artery surgery

undergoing plasmapheresis during cardiac surgery. J Extracorpol Technol

and aprotinin minimizes blood loss and requirement during cardiac surgery. J

does not reduce blood loss and product use after coronary artery bypass. J Thorac

requirements in platelet-rich plasmapheresed versus nonpheresed cardiac surgery

cardiovascular and pulmonary function: a randomized, double-blind study. Ann

1993; 8:579-06.

Thorac Cardiovasc Surg 1994;41:364-68.

Cardiovasc Surg 2010;139:621-27.

surgery. Circulation 1996;94(Suppl I):I-170.

patients. Perfusion 2009;24(6):373-80.

Extracorpor Technol 2005;37:9-14.

Cardiovasc Surg 1993;105:1007-13.

patients. Anesth Analg 1994;78:29.

Thorac Surg 2008;86:1167-73.

1993;(1):6-14.

undergoing open-heart surgery. Blood 1997;89:411-18.


[45] Gervin AS, Fischer RP. Resuscitation of trauma patiens with type-specific uncrossmatched blood. J Trauma, 1984, 24:327.
